Company Intelligence
Delineate
Delineate provides enterprise-grade artificial intelligence solutions, delivering specialized Agents for Accelerated Clinical Trial Design technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Boston, USA; Remote
- Website
- delineate.pro
- Founded
- 2025
- Employees
- 20
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 4
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Delineate is an Enterprise Software AI company based in Boston, USA; Remote, founded in 2025.
Delineate develops agents for Accelerated Clinical Trial Design.
What it builds
Agents for Accelerated Clinical Trial Design
Why It Matters
Delineate provides enterprise-grade artificial intelligence solutions, delivering specialized Agents for Accelerated Clinical Trial Design technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Delineate
Explore Delineate by Delineate. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical architecture, and…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Delineate
Industry
Products
Capabilities
- Agents for Accelerated Clinical Trial Design
Features
- Agents for Accelerated Clinical Trial Design
Country
Related companies
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Delineate do?
Delineate specializes in artificial intelligence, developing Agents for Accelerated Clinical Trial Design to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Delineate based and when was it founded?
Delineate is based in USA; Remote and was founded in 2025.
What are the main products offered by Delineate?
The flagship platform from Delineate is Agents for Accelerated Clinical Trial Design, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Delineate?
Delineate primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.